Copper induces cellular senescence in human glioblastoma multiforme cells through downregulation of Bmi-1
- 6 March 2013
- journal article
- Published by Spandidos Publications in Oncology Reports
- Vol. 29 (5), 1805-1810
- https://doi.org/10.3892/or.2013.2333
Abstract
Most human tumor cells, including glioblastoma multiforme (GBM) cells, have aberrant control of cell aging and apoptosis. Subcytotoxic concentrations of oxidative or stress‑causing agents, such as hydrogen peroxide, may induce human cell senescence. Thus, induction of tumor cells into premature senescence may provide a useful in vitro model for developing novel therapeutic strategy to combat tumors. In the present study, we assessed the molecular mechanism(s) underlying senescence in GBM cells induced by copper sulfate. Following pretreatment with subcytotoxic concentrations of copper sulfate, U87-MG tumor cells showed typical aging characteristics, including reduced cell proliferation, cell enlargement, increased level of senescence-associated β-galactosidase (SA β-gal) activity, and overexpression of several senescence-associated genes, p16, p21, transforming growth factor β-1 (TGF-β1), insulin growth factor binding protein 3 (IGFBP3) and apolipoprotein J (ApoJ). We further demonstrated that the Bmi-1 pathway was downregulated in GBM cells in parallel with the induced senescence. The present study for the first time demonstrates the ability of copper to induce GBM cell senescence by downregulating Bmi-1.Keywords
This publication has 29 references indexed in Scilit:
- Copper ability to induce premature senescence in human fibroblastsAGE, 2011
- Genetic alterations and signaling pathways in the evolution of gliomasCancer Science, 2009
- Human copper transporters: mechanism, role in human diseases and therapeutic potentialFuture Medicinal Chemistry, 2009
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialThe Lancet Oncology, 2009
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- Bmi1 Controls Tumor Development in an Ink4a/Arf-Independent Manner in a Mouse Model for GliomaCancer Cell, 2007
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaThe New England Journal of Medicine, 2005
- Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomasNature, 2004
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976